Skip to content

Middle Meningeal Artery Embolization in the Treatment of Chronic Subdural Hematoma: a Prospective Study

Middle Meningeal Artery Embolization in the Treatment of Chronic Subdural Hematoma: a Prospective Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018714
Enrollment
Unknown
Registered
2018-10-05
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Subdural Hematoma

Interventions

Group 2:Traditional surgery+MMA embolization
Group 3:MMA embolization

Sponsors

The Affiliated Hospital of Binzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged at least 18 years; 2. A diagnosis of chronic subdural hematoma (cSDH) based on brain imaging is needed; 3. Failure in conservative management; 4. One or more symptoms attributable to cSDH including headache, cognitive impairment, gait instability, seizure, or mild focal neurologic deficit.

Exclusion criteria

Exclusion criteria: 1. Acute subdural hematomas; 2. The subdural hematoma is causing mass effect significant enough to cause marked or progressive neurologic impairment; 3. Any requirement for urgent surgical evacuation is necessary; 4. Poor medical condition and life expectancy is less than 6 months; 5. As assessed on angiogram, the patient was not suitable for endovascular treatment.

Design outcomes

Primary

MeasureTime frame
Recurrence rate;Improvement rate of clinical symptoms;Reoperation rate;

Secondary

MeasureTime frame
Cure rate;

Countries

China

Contacts

Public ContactZefu Li

The Affiliated Hospital of Binzhou Medical University

zefuli@163.com+86 13954398400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026